A mitochondria-targeted synthetic peptide studied in preclinical research, in pharmaceutical clinical development under the same compound class. The Peptide Index files it under Mitochondrial-targeted peptide. Vendors also list it as “Elamipretide”.
As of Sep 25, 2026, the lowest listed price is $1.00/mg and the median current listing is $5.50/mg, across 70 vendors (105 comparable single-compound listings). Prices are normalized to US dollars per milligram of peptide, exclude shipping, and are refreshed nightly.
In the nightly price history, the daily median fell from $6.90/mg on Jul 14, 2026 to $6.25/mg on Sep 25, 2026 (−9.4%), based on 67 observed days. Days the crawl missed are left out, not filled in. The daily series is taken across each day’s comparable listings, so it can differ slightly from the current-listings median above. See the full SS-31 price history chart.
| Vendor | $/mg | Price (USD) | Package |
|---|---|---|---|
| Rarev Biolabs | $1.00/mg | $50.00 | 50mg vial |
| UK SARMs | $1.27/mg | $63.49 | 50mg vial |
| GenX Bio | $1.78/mg | $89.00 | 50mg vial |
| Nu Life Peptides | $1.90/mg | $95.00 | 50mg vial |
| Pure US Peptide | $2.08/mg | $103.95 | 50mg vial |
Each vendor name links to its public-record trust profile. The SS-31 price page lists every current listing.
Every night The Peptide Index reads vendors’ public catalog pages, records the listed price and stated peptide content, and divides one by the other to get a comparable $/mg. Blends and topical/cosmetic products are excluded from single-compound figures. Read the full methodology and how vendor signals are checked.